References
- Imbeaud S., Belvbille C., Messika-Zeitoun L. et al. A 27 basepair deletion of THA antimullerian type II receptor gene is the most common cause of THA persistent mullerian duct syndrome. Hum Mol Genet, 1996, 5: 1269–77.
- Teixeira J., Maheswaran S., Donahoe P. K. Mullerian Inhibiting Substance A: a case report. Instructive Developmental Hormone with Diagnostic and Possible Therapeutic Applications. Endocr Rev, 2001, 22: 657–74.
- Lima M., Domini M., Libra M. Persistent mullerian duct syndrome associated with transverse testicular ectopia: a case report. Eur J Pediatr Surg, 1997, 7: 60–2.
- Narlawar RS, Shah JS, Parikh V, Patankar T. Persistent mullerian duct syndrome with teratoma in an ectopic testis: imaging features. Eur Radiol, 2001, 11: 955–8.
- Josso N., Picard J. Y., Imbeaud S., Carre-Eusebe D., Zeller J., Adamsbaum C. The persistent mullerian duct syndrome: a rare cause of cryptorchidism. Eur J Pediatr, 1993, 152: 76–8.
- Zeller J., Imbeaud S., Rey R. et al. Persistent mullerian duct syndrome (males with uterus): a pediatric problem. Arch Pediatr, 1994, 1: 991–7.
- Baker M. L., Hutson J. M. Serum levels of mullerian inhibiting substance in boys throughout puberty and in the first two years of life. J Clin Endocr Metab, 1993, 76: 245.
- Weiss E. B., Kiefer J. H., Rowlatt U. F., Rosenthal I. M. Persistent mullerian duct syndrome in male identical twins. Pediatrics, 1978, 61: 797.
- Souto C. A. V., Da Costa Oliveira M., Telöken C., Paskulin G., Hoffmann K. Persistence of mullerian duct derivative syndrome in 2 male patients with bilateral cryptorchidism. J Urol, 1995, 153: 1637–8.
- Berkmen F. Persistent mullerian duct syndrome with or without transverse testicular ectopia and testis tumours. British J Urol, 1997, 79: 122–6.
- Cohen-Haguenauer O., Picard J. Y., Mattéi M. G. et al. Mapping of the gene for anti-mullerian hormone to the short arm of human chromosome, 19. Cytogenet Cell Genet, 1987, 44: 2.